Januvia contains Sitagliptin, a DPP-4 inhibitor that helps control blood sugar levels in adults with type 2 diabetes by increasing the levels of incretin hormones, which increase insulin release.
Indications: Type 2 diabetes mellitus.
Dosage: 100 mg once daily, with or without food.
Side Effects: Nasopharyngitis, headache, upper respiratory infection, hypoglycemia (when used with insulin or sulfonylureas).
Precautions: Not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Regular monitoring of blood sugar levels is necessary.
Storage: Store at room temperature, away from moisture and heat.
| Dosage Form | Tablet |
| Medicine Type | Allopathic |
| Active Ingredient | Sitagliptin Phosphate |
| Strength | 100 Mg |
| Chemical Class | Pyrazine Derivative |
| Drug Name | Januvia |
| Route Of Administration | Oral |
| Prescription Status | Prescription Only |
| Color | White |
| Storage Requirements | Store At 30°C |
| Usage | Oral Use Only |
| Treat For | Type 2 Diabetes Mellitus |
| Common Side Effects | Headache, Nasopharyngitis, Nausea |
| Drug Interactions | May Interact With Other Antidiabetic Agents |
| Pack Size | 1 Strip Of 7 Film Coated Tablets |
| Supplier | Medicina Overseas Private Limited |
| Origin | Made In India |
